
Invus Opportunities
Description
Invus Opportunities is the dedicated growth equity arm of The Invus Group, a distinguished multi-billion dollar evergreen investment firm based in New York. Established in 2007, this fund focuses on providing substantial capital to private, growth-stage companies that have demonstrated strong product-market fit and are generating significant revenue. Their investment philosophy centers on identifying and backing businesses with proven models ready for accelerated expansion, rather than early-stage ventures.
The firm's investment strategy is broad, targeting disruptive companies across key sectors including consumer, healthcare, software, and tech-enabled services. Invus Opportunities is flexible in its participation, capable of leading financing rounds or co-investing alongside other prominent investors in syndicated deals. This adaptability allows them to engage with a diverse range of opportunities, supporting companies as they scale operations, expand market reach, and solidify their competitive advantages within their respective industries.
With over $1.5 billion in assets under management specifically for its Opportunities fund, Invus Opportunities is well-positioned to make impactful investments. The fund typically deploys first checks ranging from $20 million to $100 million per company, reflecting its commitment to providing meaningful growth capital. This substantial funding enables portfolio companies to invest in critical areas such as product development, market expansion, and team building, ultimately driving long-term value creation and market leadership.
Investor Profile
Invus Opportunities has backed more than 52 startups, with 4 new investments in the last 12 months alone. The firm has led 8 rounds, about 15% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Indonesia.
- Strong thematic focus on Financial Services, Health Care, FinTech.
- Typical check size: $20M – $100M.
Stage Focus
- Series C (21%)
- Series B (17%)
- Series A (15%)
- Series D (12%)
- Series Unknown (12%)
- Series E (8%)
- Seed (6%)
- Post Ipo Equity (4%)
- Private Equity (4%)
- Secondary Market (2%)
Country Focus
- United States (71%)
- United Kingdom (6%)
- Indonesia (4%)
- Mexico (4%)
- Brazil (4%)
- India (4%)
- Canada (2%)
- Luxembourg (2%)
- Israel (2%)
- France (2%)
Industry Focus
- Financial Services
- Health Care
- Fintech
- Software
- Medical
- Medical Device
- Information Technology
- Finance
- E-commerce
- Biotechnology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.